Drug profile

The FDA adverse-event record for Albuterol

88 FDA reports name Albuterol, a high-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#827 of 2,679
by report volume (all drugs)
88
adverse-event reports
25.0%
death-coded share
Cat
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Albuterol ranks #827 of 2679 by total reports (88) and #171 of 1130 by death-coded share (25.0%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#827
This drug, reports of 2679
#171
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Albuterol has 88 reports now versus 87 in that prior snapshot: 1 more (1.1%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Albuterol changes

Signature read: Albuterol's 25.0% death-coded share is among the highest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
88
Total Reports
22
Deaths Reported
25.0%
Death-coded share of reports

Active Ingredients

Albuterol

Administration Routes

UnknownRespiratory (Inhalation)OralOther

Species Affected

Cat 43
Dog 33
Human 9
Horse 3

Most Affected Breeds

Domestic Shorthair 27
Unknown 9
Terrier - Yorkshire 6
Domestic Longhair 3
Cat (unknown) 3
Pug 3
American Shorthair 2
Shih Tzu 2
Maltese 2
Dog (unknown) 2

Most Reported Reactions

Death 14
Abnormal radiograph finding 14
Vomiting 11
Not eating 10
Weight loss 9
Cough 9
Death by euthanasia 9
Other abnormal test result NOS 9
Breathing difficulty 8
Lethargy (see also Central nervous system depression in Neurological) 8
Behavioural disorder NOS 7
Lack of efficacy - NOS 7

Outcome Breakdown

Ongoing
28 (32.2%)
Outcome Unknown
20 (23.0%)
Recovered/Normal
15 (17.2%)
Died
13 (14.9%)
Euthanized
9 (10.3%)
Recovered with Sequela
2 (2.3%)

Albuterol: high death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

High-volume nationwide drug peers

Two openFDA-derived peer sets for Albuterol, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

Similar death-coded share

Nearest other drugs by death-coded share (25.0% here), distinct from the volume row.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Albuterol (#827 of 2,679 by report volume); death-coded 25.0%. PlainBreed drug row · death-coded share stamp 25.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →